Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors.

Published

Journal Article

We believe the proposed model is appropriate to our current state of knowledge and recognize that FDA regulations will evolved as the field evolves. We thank you for the opportunity to work with FDA as its regulatory strategy is developed in the near future.

Full Text

Duke Authors

Cited Authors

  • Shpall, EJ

Published Date

  • August 1997

Published In

Volume / Issue

  • 6 / 4

Start / End Page

  • 287 - 289

PubMed ID

  • 9377066

Pubmed Central ID

  • 9377066

International Standard Serial Number (ISSN)

  • 1061-6128

Digital Object Identifier (DOI)

  • 10.1089/scd.1.1997.6.287

Language

  • eng

Conference Location

  • United States